ARCHIVES

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

At Its Launch, STAR Trial Inherits Baggage Of Its Predecessor, P-1 Tamoxifin Study

June 4, 1999

MSKCC In Outreach Agreement With Phelps

December 1, 1995

In Brief: BRCA 2 Gene sequence Published; CALGB To Mark 40th Anniversary

March 8, 1996

How Construction Grantees Will Spend Their $30 Million

September 12, 1975

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

April 17, 2009

8 Centers Awarded Comprehensive Designation

February 15, 1991